Neo Cremar Co., Ltd. (311390) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Neo Cremar Co., Ltd. (311390:KRX), powered by AI.

Current Price
₩4,370
P/E Ratio
18.5
Market Cap
55.3B
Sector
Basic Materials
What is the Neo Cremar Co., Ltd. stock price forecast?

Neo Cremar Co., Ltd. is currently trading at ₩4,370. View real-time AI analysis on Alpha Lenz.

What is Neo Cremar Co., Ltd. insider trading activity?

View the latest insider trading data for Neo Cremar Co., Ltd. on Alpha Lenz.

What is Neo Cremar Co., Ltd.'s P/E ratio?

Neo Cremar Co., Ltd.'s P/E ratio is 18.5.

Neo Cremar Co., Ltd.

KRX · 311390
₩4,370-140(-3.10%)Market closedKRX regular session 09:00–15:30 KST
Ask about Neo Cremar Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Neo Cremar Co., Ltd. trades at a P/E of 18.5 (fair value) with modest ROE of 4.1%. 3Y revenue CAGR of 45.3% highlights clear growth momentum.

Ask for details

Company Overview

Neo Cremar Co., Ltd. is an innovative biochemical company specializing in the development and production of functional food ingredients and biopolymers. The company's primary function is to manufacture products that enhance the nutritional value and functional properties of food and beverage offerings. Notable features of Neo Cremar's product lines include probiotics, prebiotics, and various natural extracts that serve the diverse needs of the nutrition, cosmetics, and pharmaceutical sectors. In the financial market, Neo Cremar Co., Ltd. plays a significant role by supplying essential bio-ingredients that support the global trend towards healthier eating habits and natural products. Its contributions are crucial for manufacturers aiming to align with consumer demand for wellness-enhancing food products. The company’s focus on research and development underscores its commitment to innovation, positioning it as a key player in the biochemistry and functional foods industries. Through strategic partnerships and a robust distribution network, Neo Cremar is an important entity in both domestic and international markets, helping shape modern dietary trends and contributing to advancements in health-related product offerings.

CEO한기수, 이준우 (공동대표이사)
SectorBasic Materials
IndustrySpecialty Chemicals
Employees66

Company Statistics

FY 2025

Profile

₩55,297,057,930Market Cap
₩81,943,689,100Revenue
12.65MShares Out
66Employees

Margins

36.15%Gross
17.65%EBITDA
6.60%Operating
7.29%Pre-Tax
6.31%Net

Valuation

18.54P/E
0.75P/B
0.67EV/Sales
7.88EV/EBITDA
3.71P/FCF

Growth (CAGR)

45.32%Rev 3Yr
22.40%Rev 5Yr
56.16%Op Inc 3Yr
33.85%Op Inc 5Yr
N/ANet Inc 3Yr
30.50%Net Inc 5Yr

Returns

2.87%ROA
4.13%ROE
4.11%ROIC

Financial Health

₩32,965,116,730Cash & Cash Equivalents
₩2,541,174,110Net Debt
24.26%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Neo Cremar Co., Ltd. (ticker: 311390) is a company listed on KRX in the Basic Materials sector (Specialty Chemicals). It has approximately 66 employees. Market cap is $55.3B.

The current price is ₩4,370 with a P/E ratio of 18.54x and P/B of 0.75x.

ROE is 4.13% and operating margin is 6.60%. Annual revenue is $81.9B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Neo Cremar Co., Ltd. (Basic Materials) Stock Forecast & Analysis ₩4,370 | Alpha Lenz